Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epithelium, Corneal | 7 | 2024 | 13 | 3.730 |
Why?
|
| Cornea | 10 | 2024 | 140 | 3.270 |
Why?
|
| Corneal Injuries | 6 | 2023 | 7 | 3.110 |
Why?
|
| Obesity | 6 | 2024 | 118 | 3.040 |
Why?
|
| Mice, Inbred C57BL | 17 | 2024 | 195 | 2.270 |
Why?
|
| Animals | 38 | 2025 | 1817 | 2.060 |
Why?
|
| Diet, High-Fat | 5 | 2024 | 35 | 2.050 |
Why?
|
| Corneal Stroma | 5 | 2024 | 17 | 2.050 |
Why?
|
| Mice | 27 | 2025 | 719 | 2.020 |
Why?
|
| Wound Healing | 7 | 2021 | 15 | 1.980 |
Why?
|
| Microscopy, Electron, Scanning | 5 | 2024 | 37 | 1.960 |
Why?
|
| Dyslipidemias | 2 | 2020 | 4 | 1.380 |
Why?
|
| Blood Platelets | 6 | 2021 | 8 | 1.360 |
Why?
|
| Neutrophils | 4 | 2021 | 19 | 1.170 |
Why?
|
| Male | 15 | 2024 | 2770 | 0.890 |
Why?
|
| Sucrose | 1 | 2023 | 1 | 0.840 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2014 | 2 | 0.810 |
Why?
|
| Eye Injuries | 2 | 2014 | 4 | 0.800 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 8 | 0.770 |
Why?
|
| Disease Models, Animal | 9 | 2024 | 242 | 0.760 |
Why?
|
| Feeding Behavior | 1 | 2021 | 47 | 0.740 |
Why?
|
| Hypertrophy | 1 | 2020 | 5 | 0.720 |
Why?
|
| Face | 1 | 2021 | 25 | 0.720 |
Why?
|
| Meibomian Glands | 1 | 2020 | 4 | 0.720 |
Why?
|
| Mast Cells | 5 | 2021 | 8 | 0.720 |
Why?
|
| Tears | 1 | 2020 | 21 | 0.710 |
Why?
|
| Hyperglycemia | 1 | 2020 | 10 | 0.700 |
Why?
|
| Diet | 1 | 2019 | 40 | 0.640 |
Why?
|
| Integrins | 2 | 2020 | 3 | 0.630 |
Why?
|
| Exocytosis | 7 | 2021 | 7 | 0.630 |
Why?
|
| Corneal Keratocytes | 2 | 2015 | 4 | 0.600 |
Why?
|
| Neurons | 1 | 2019 | 131 | 0.590 |
Why?
|
| Interleukins | 1 | 2016 | 3 | 0.550 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 24 | 0.540 |
Why?
|
| Nerve Tissue Proteins | 2 | 2017 | 35 | 0.510 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2021 | 3 | 0.500 |
Why?
|
| Thrombosis | 3 | 2020 | 6 | 0.490 |
Why?
|
| Microfibrils | 1 | 2015 | 1 | 0.480 |
Why?
|
| Elastin | 1 | 2015 | 2 | 0.480 |
Why?
|
| Myocytes, Cardiac | 3 | 2025 | 40 | 0.480 |
Why?
|
| Munc18 Proteins | 3 | 2019 | 3 | 0.470 |
Why?
|
| Mice, Knockout | 8 | 2024 | 143 | 0.470 |
Why?
|
| Middle Cerebral Artery | 1 | 2012 | 1 | 0.390 |
Why?
|
| Myocardium | 3 | 2025 | 35 | 0.390 |
Why?
|
| Connexins | 1 | 2012 | 6 | 0.390 |
Why?
|
| Tissue Fixation | 1 | 2011 | 4 | 0.380 |
Why?
|
| Adipose Tissue | 2 | 2021 | 18 | 0.370 |
Why?
|
| Extracellular Matrix | 2 | 2024 | 14 | 0.370 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 4 | 0.350 |
Why?
|
| Time Factors | 2 | 2021 | 176 | 0.350 |
Why?
|
| Integrin beta1 | 2 | 2024 | 10 | 0.340 |
Why?
|
| Heart | 2 | 2025 | 46 | 0.340 |
Why?
|
| Humans | 11 | 2024 | 5485 | 0.320 |
Why?
|
| Cell Movement | 4 | 2024 | 64 | 0.320 |
Why?
|
| Hemostasis | 2 | 2019 | 2 | 0.310 |
Why?
|
| Tomography, Optical Coherence | 1 | 2011 | 217 | 0.310 |
Why?
|
| CD18 Antigens | 2 | 2021 | 4 | 0.300 |
Why?
|
| Cyprinidae | 2 | 2019 | 3 | 0.300 |
Why?
|
| Heart Ventricles | 2 | 2025 | 25 | 0.290 |
Why?
|
| Immunohistochemistry | 4 | 2020 | 30 | 0.290 |
Why?
|
| Membrane Proteins | 2 | 2018 | 49 | 0.280 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2019 | 73 | 0.270 |
Why?
|
| Cell Degranulation | 3 | 2021 | 3 | 0.270 |
Why?
|
| Female | 8 | 2024 | 2816 | 0.260 |
Why?
|
| Anaphylaxis | 3 | 2021 | 3 | 0.260 |
Why?
|
| Secretory Vesicles | 3 | 2021 | 3 | 0.240 |
Why?
|
| Endocardium | 1 | 2025 | 6 | 0.240 |
Why?
|
| Macrophages | 4 | 2021 | 29 | 0.240 |
Why?
|
| Cell Communication | 1 | 2025 | 16 | 0.240 |
Why?
|
| Fibronectins | 1 | 2024 | 13 | 0.230 |
Why?
|
| Organogenesis | 2 | 2025 | 10 | 0.230 |
Why?
|
| Collagen | 3 | 2024 | 34 | 0.220 |
Why?
|
| Lung | 3 | 2021 | 42 | 0.220 |
Why?
|
| Homeostasis | 2 | 2020 | 30 | 0.210 |
Why?
|
| Aging | 1 | 2024 | 127 | 0.200 |
Why?
|
| Embryo, Nonmammalian | 2 | 2019 | 19 | 0.200 |
Why?
|
| Intra-Abdominal Fat | 1 | 2021 | 1 | 0.200 |
Why?
|
| Basement Membrane | 1 | 2021 | 3 | 0.200 |
Why?
|
| Cicatrix | 1 | 2021 | 3 | 0.200 |
Why?
|
| Ascariasis | 1 | 2021 | 1 | 0.200 |
Why?
|
| Ascaris suum | 1 | 2021 | 1 | 0.200 |
Why?
|
| Lung Diseases | 1 | 2021 | 2 | 0.200 |
Why?
|
| Anemia | 1 | 2021 | 2 | 0.200 |
Why?
|
| Cell Membrane | 2 | 2020 | 51 | 0.190 |
Why?
|
| Vasculitis | 1 | 2021 | 1 | 0.190 |
Why?
|
| Venules | 1 | 2021 | 1 | 0.190 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2021 | 1 | 0.190 |
Why?
|
| Regeneration | 3 | 2021 | 15 | 0.190 |
Why?
|
| Erythrocytes | 1 | 2021 | 12 | 0.190 |
Why?
|
| Hyperemia | 1 | 2021 | 4 | 0.190 |
Why?
|
| Qb-SNARE Proteins | 1 | 2021 | 1 | 0.180 |
Why?
|
| Qc-SNARE Proteins | 1 | 2021 | 1 | 0.180 |
Why?
|
| Connective Tissue | 1 | 2021 | 2 | 0.180 |
Why?
|
| Cholesterol Esters | 1 | 2020 | 1 | 0.180 |
Why?
|
| Sphingomyelins | 1 | 2020 | 1 | 0.180 |
Why?
|
| Ceramides | 1 | 2020 | 4 | 0.180 |
Why?
|
| Mice, Obese | 1 | 2020 | 9 | 0.180 |
Why?
|
| Epididymis | 1 | 2020 | 5 | 0.180 |
Why?
|
| Caveolins | 1 | 2020 | 1 | 0.180 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 4 | 0.180 |
Why?
|
| Glucocorticoids | 1 | 2020 | 3 | 0.180 |
Why?
|
| Trabecular Meshwork | 1 | 2020 | 6 | 0.180 |
Why?
|
| Dexamethasone | 1 | 2020 | 7 | 0.180 |
Why?
|
| Triglycerides | 1 | 2020 | 7 | 0.180 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 19 | 0.180 |
Why?
|
| Leukocytes | 1 | 2020 | 6 | 0.180 |
Why?
|
| Body Composition | 1 | 2020 | 16 | 0.180 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2024 | 14 | 0.180 |
Why?
|
| Coronary Thrombosis | 1 | 2020 | 1 | 0.170 |
Why?
|
| Scavenger Receptors, Class E | 1 | 2020 | 1 | 0.170 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2020 | 3 | 0.170 |
Why?
|
| Phagocytosis | 2 | 2021 | 6 | 0.170 |
Why?
|
| Barium | 1 | 2019 | 1 | 0.170 |
Why?
|
| Cell Fusion | 1 | 2019 | 5 | 0.170 |
Why?
|
| X-Ray Microtomography | 1 | 2019 | 5 | 0.170 |
Why?
|
| Cerebrovascular Circulation | 1 | 2019 | 8 | 0.170 |
Why?
|
| Exocrine Glands | 1 | 2019 | 1 | 0.170 |
Why?
|
| Goblet Cells | 1 | 2019 | 3 | 0.170 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 116 | 0.160 |
Why?
|
| Mucins | 1 | 2019 | 4 | 0.160 |
Why?
|
| Respiratory Mucosa | 1 | 2019 | 5 | 0.160 |
Why?
|
| Gene Deletion | 2 | 2018 | 15 | 0.160 |
Why?
|
| Asthma | 1 | 2019 | 11 | 0.160 |
Why?
|
| Qa-SNARE Proteins | 1 | 2018 | 4 | 0.160 |
Why?
|
| Lipid Metabolism | 2 | 2016 | 14 | 0.160 |
Why?
|
| Hypersensitivity | 1 | 2018 | 1 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 12 | 0.140 |
Why?
|
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2016 | 1 | 0.140 |
Why?
|
| Ophthalmic Solutions | 1 | 2016 | 7 | 0.140 |
Why?
|
| Glycoconjugates | 1 | 2016 | 1 | 0.140 |
Why?
|
| Plant Lectins | 1 | 2016 | 2 | 0.140 |
Why?
|
| Cells, Cultured | 2 | 2020 | 134 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 21 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 24 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 10 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 18 | 0.130 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2016 | 2 | 0.130 |
Why?
|
| Liver X Receptors | 1 | 2016 | 18 | 0.130 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2016 | 1 | 0.130 |
Why?
|
| Myofibrils | 1 | 2016 | 4 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2025 | 225 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2016 | 11 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 27 | 0.130 |
Why?
|
| Repressor Proteins | 1 | 2016 | 14 | 0.130 |
Why?
|
| Cell Nucleus | 1 | 2016 | 16 | 0.130 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 23 | 0.130 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2016 | 18 | 0.130 |
Why?
|
| Muscular Atrophy | 1 | 2016 | 21 | 0.130 |
Why?
|
| Mitochondria | 1 | 2016 | 23 | 0.130 |
Why?
|
| Stem Cells | 1 | 2016 | 33 | 0.130 |
Why?
|
| Amebicides | 1 | 2015 | 2 | 0.130 |
Why?
|
| Acanthamoeba castellanii | 1 | 2015 | 2 | 0.130 |
Why?
|
| Contact Lens Solutions | 1 | 2015 | 8 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2016 | 69 | 0.120 |
Why?
|
| Cell-Derived Microparticles | 1 | 2015 | 2 | 0.120 |
Why?
|
| P-Selectin | 1 | 2015 | 1 | 0.120 |
Why?
|
| Fibrillins | 1 | 2015 | 1 | 0.120 |
Why?
|
| Eye | 1 | 2015 | 20 | 0.120 |
Why?
|
| Neoplasms | 1 | 2016 | 99 | 0.120 |
Why?
|
| Pupil | 1 | 2015 | 45 | 0.120 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 16 | 0.120 |
Why?
|
| Morphogenesis | 2 | 2025 | 28 | 0.120 |
Why?
|
| Goldfish | 1 | 2014 | 1 | 0.110 |
Why?
|
| Antibodies, Blocking | 1 | 2014 | 1 | 0.110 |
Why?
|
| Integrin beta3 | 1 | 2014 | 3 | 0.110 |
Why?
|
| Keratitis | 1 | 2014 | 3 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2024 | 120 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 49 | 0.110 |
Why?
|
| Cell Differentiation | 3 | 2020 | 75 | 0.110 |
Why?
|
| Dry Eye Syndromes | 1 | 2013 | 12 | 0.100 |
Why?
|
| Corneal Pachymetry | 2 | 2024 | 7 | 0.100 |
Why?
|
| Androgens | 1 | 2012 | 10 | 0.100 |
Why?
|
| Middle Aged | 3 | 2024 | 1100 | 0.100 |
Why?
|
| Lipids | 1 | 2012 | 21 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 21 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 35 | 0.100 |
Why?
|
| Autophagy | 1 | 2012 | 31 | 0.100 |
Why?
|
| Isoquinolines | 1 | 2012 | 5 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 16 | 0.100 |
Why?
|
| Rats, Long-Evans | 1 | 2012 | 19 | 0.100 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2012 | 23 | 0.100 |
Why?
|
| Fluorescent Dyes | 1 | 2012 | 32 | 0.100 |
Why?
|
| Microwaves | 1 | 2011 | 3 | 0.090 |
Why?
|
| Animals, Newborn | 1 | 2011 | 37 | 0.090 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2010 | 3 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 1 | 2010 | 6 | 0.090 |
Why?
|
| Rats | 1 | 2012 | 251 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2024 | 41 | 0.090 |
Why?
|
| Phenotype | 1 | 2010 | 73 | 0.090 |
Why?
|
| Microscopy, Electron | 2 | 2021 | 9 | 0.080 |
Why?
|
| Biomarkers | 2 | 2020 | 87 | 0.080 |
Why?
|
| Aged | 2 | 2024 | 860 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2020 | 30 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2019 | 31 | 0.070 |
Why?
|
| Nanotubes | 1 | 2025 | 9 | 0.060 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2024 | 9 | 0.060 |
Why?
|
| Cell Shape | 1 | 2024 | 10 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2024 | 11 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 175 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 22 | 0.050 |
Why?
|
| Larva | 1 | 2021 | 12 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2021 | 29 | 0.050 |
Why?
|
| Cytokines | 1 | 2021 | 37 | 0.050 |
Why?
|
| Microcirculation | 1 | 2021 | 7 | 0.050 |
Why?
|
| Models, Animal | 1 | 2021 | 25 | 0.050 |
Why?
|
| Corneal Topography | 1 | 2021 | 37 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2020 | 19 | 0.050 |
Why?
|
| Actins | 1 | 2020 | 23 | 0.040 |
Why?
|
| Elasticity | 1 | 2020 | 35 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2020 | 1 | 0.040 |
Why?
|
| Suction | 1 | 2020 | 1 | 0.040 |
Why?
|
| Thrombectomy | 1 | 2020 | 1 | 0.040 |
Why?
|
| Apolipoprotein B-100 | 1 | 2020 | 1 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2020 | 4 | 0.040 |
Why?
|
| Contrast Media | 1 | 2019 | 8 | 0.040 |
Why?
|
| Tretinoin | 1 | 2019 | 3 | 0.040 |
Why?
|
| Biomechanical Phenomena | 1 | 2020 | 176 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2020 | 132 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 2019 | 6 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 10 | 0.040 |
Why?
|
| Cell Count | 1 | 2018 | 33 | 0.040 |
Why?
|
| Transcriptome | 1 | 2019 | 47 | 0.040 |
Why?
|
| Kinetics | 1 | 2018 | 79 | 0.040 |
Why?
|
| Platelet Activation | 1 | 2018 | 1 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 5 | 0.040 |
Why?
|
| Membrane Fusion | 1 | 2018 | 1 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2018 | 19 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2017 | 16 | 0.040 |
Why?
|
| Protein Transport | 1 | 2017 | 30 | 0.040 |
Why?
|
| Adult | 1 | 2024 | 1687 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2016 | 9 | 0.030 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2016 | 3 | 0.030 |
Why?
|
| Zebrafish | 1 | 2016 | 21 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2016 | 25 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 15 | 0.030 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2016 | 2 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2016 | 16 | 0.030 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 2 | 0.030 |
Why?
|
| Sarcolemma | 1 | 2016 | 6 | 0.030 |
Why?
|
| Pneumonia | 1 | 2016 | 20 | 0.030 |
Why?
|
| Protein Binding | 1 | 2016 | 118 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2016 | 9 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 24 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 18 | 0.030 |
Why?
|
| Organ Size | 1 | 2016 | 31 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 19 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 30 | 0.030 |
Why?
|
| Muscle Development | 1 | 2016 | 13 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 50 | 0.030 |
Why?
|
| Amebiasis | 1 | 2015 | 2 | 0.030 |
Why?
|
| Acanthamoeba Keratitis | 1 | 2015 | 2 | 0.030 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2015 | 2 | 0.030 |
Why?
|
| Trophozoites | 1 | 2015 | 2 | 0.030 |
Why?
|
| Disinfection | 1 | 2015 | 4 | 0.030 |
Why?
|
| Biguanides | 1 | 2015 | 3 | 0.030 |
Why?
|
| Propylamines | 1 | 2015 | 4 | 0.030 |
Why?
|
| Reference Standards | 1 | 2015 | 13 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2015 | 7 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2015 | 1 | 0.030 |
Why?
|
| Cell Surface Extensions | 1 | 2015 | 1 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2015 | 25 | 0.030 |
Why?
|
| beta Catenin | 1 | 2015 | 8 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2015 | 9 | 0.030 |
Why?
|
| Capillaries | 1 | 2015 | 8 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2016 | 59 | 0.030 |
Why?
|
| Polymers | 1 | 2015 | 42 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2015 | 48 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 17 | 0.030 |
Why?
|
| Conjunctiva | 1 | 2013 | 13 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2012 | 2 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2013 | 81 | 0.030 |
Why?
|
| RNA Interference | 1 | 2012 | 23 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 35 | 0.030 |
Why?
|
| Cell Survival | 1 | 2012 | 57 | 0.030 |
Why?
|